Suppr超能文献

急性肺损伤和急性呼吸窘迫综合征的替代和自然疗法。

Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome.

机构信息

Division of Pulmonology, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA.

出版信息

Biomed Res Int. 2018 May 16;2018:2476824. doi: 10.1155/2018/2476824. eCollection 2018.

Abstract

INTRODUCTION

Acute respiratory distress syndrome (ARDS) is a complex clinical syndrome characterized by acute inflammation, microvascular damage, and increased pulmonary vascular and epithelial permeability, frequently resulting in acute respiratory failure and death. Current best practice for ARDS involves "lung-protective ventilation," which entails low tidal volumes and limiting the plateau pressures in mechanically ventilated patients. Although considerable progress has been made in understanding the pathogenesis of ARDS, little progress has been made in the development of specific therapies to combat injury and inflammation.

AREAS COVERED

In recent years, several natural products have been studied in experimental models and have been shown to inhibit multiple inflammatory pathways associated with acute lung injury and ARDS at a molecular level. Because of the pleiotropic effects of these agents, many of them also activate antioxidant pathways through nuclear factor erythroid-related factor 2, thereby targeting multiple pathways. Several of these agents are prescribed for treatment of inflammatory conditions in the Asian subcontinent and have shown to be relatively safe.

EXPERT COMMENTARY

Here we review natural remedies shown to attenuate lung injury and inflammation in experimental models. Translational human studies in patients with ARDS may facilitate treatment of this devastating disease.

摘要

简介

急性呼吸窘迫综合征(ARDS)是一种复杂的临床综合征,其特征为急性炎症、微血管损伤以及肺血管和上皮通透性增加,常导致急性呼吸衰竭和死亡。目前 ARDS 的最佳治疗方法是“肺保护性通气”,即对机械通气患者采用小潮气量和限制平台压。尽管人们在理解 ARDS 的发病机制方面取得了相当大的进展,但在开发针对损伤和炎症的特定治疗方法方面却鲜有进展。

涵盖领域

近年来,已有多种天然产物在实验模型中进行了研究,并已证明其可在分子水平上抑制与急性肺损伤和 ARDS 相关的多种炎症途径。由于这些药物的多效性,其中许多药物还通过核因子红细胞相关因子 2 激活抗氧化途径,从而针对多种途径。这些药物中有几种被用于治疗亚洲次大陆的炎症性疾病,并且已被证明相对安全。

专家评论

本文综述了在实验模型中已被证明可减轻肺损伤和炎症的天然疗法。对 ARDS 患者进行转化性人体研究可能有助于治疗这种毁灭性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/5976962/766e5ea533d5/BMRI2018-2476824.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验